ePharmaSolutions Named 2014 Disruptive Innovator Of The Year For Its ePharmaONE eClinical Platform

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PLYMOUTH MEETING, Pa., Sept. 18, 2014 /PRNewswire/ -- ePharmaSolutions, the leading provider of eClinical trial solutions, was recognized as the Disruptive Innovator of the Year at Dpharm 2014 for its ePharmaONE cloud-based eClinical platform. This solution includes an integrated clinical trial portal and electronic trial master file (eTMF), a remote monitoring application, eSource and electronic informed-consent solution, and ePharmaSolutions' ReferralPlus+ patient screening and matching technology.

The third Annual Quick Fire Disruptive Technology Presentations which follow an "American Idol/Shark Tank" format featured a number of innovators who were questioned and challenged by a panel of judges to determine how their technology was disruptive in advancing clinical development. ePharmaSolutions presented, "A Paperless Clinical Trial," which demonstrated how sponsors can quickly identify, activate, and obtain approval for sites remotely, and in a completely paperless environment. At the same time, patients can use its ReferralPlus+ solution to find, screen, match, and electronically consent to studies that are best suited for them.

"We assumed that many of the competitors would demonstrate point solutions like a stand-alone eTMF or mobile app, so we really wanted to show how ePharmaONE ties all those solutions together through a single, cloud-based eClinical platform. PharmaONE provides a paperless, virtual and mobile solution for all stakeholders in the process the sponsors, sites, subjects, and vendors. We believe that to be a truly disruptive technology," said Lisa La Luna, ePharmaSolutions' senior vice president of business development.

ePharmaONE is the first cloud-based solution to provide a full suite of interoperable workflow apps that facilitate and track online site feasibility and activation, study training, safety letter distribution, patient recruitment, eSource, remote monitoring, and eTMF. Each app is fully integrated within the eClinical platform, allowing for centralization of study-related tasks (such as approval of documents, visit reports and training) for study teams and site users. The integration also supports a fully-electronic clinical document management process from the sites to the eTMF through to the publishing application, using digital signature, tablet-based document capture, and/or 2D bar code intelligent routing.

"We had a great time pulling together a demonstration that showed how far we have come in providing a paperless end-to-end eClinical trial solution from a single, cloud-based platform," added Lance Converse, founder and CEO of ePharmaSolutions. "We were up against some very strong competitors, and are thrilled to have been selected as the 'Disruptive Innovator of the Year' by a team of sophisticated and experienced judges."

About ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions has won multiple industry awards for its eClinical platform which now hosts more than 350,000 clinical researchers in 130 countries for the leading pharmaceutical companies and CROs. ePharmaSolutions is headquartered in Plymouth Meeting, PA with offices in Slough, UK. ePharmaSolutions new address is 1 IMS Drive, Suite 200, Plymouth Meeting, PA 19462. www.epharmasolutions.com.

About Dpharm
Dpharm: Disruptive Innovations to Advance Clinical Trials is a conference dedicated to exploring and addressing areas where there is significant innovation in clinical trials. It aims to bring together an audience of out-of-the-box thinkers determined to make clinical trials more affordable and efficient, with higher quality data and a far better experience for patients. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results. For more information, please visit: http://theconferenceforum.org/conferences/disruptive-innovations/overview.

SOURCE ePharmaSolutions



Help employers find you! Check out all the jobs and post your resume.

Back to news